Llwytho...
Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
OBJECTIVE: To explore the efficacy of botulinum toxin type A (BTX-A) therapy in relieving anxiety and depression in patients with hemifacial spasm (HFS) and benign essential blepharospasm (BEB). PATIENTS AND METHOD: Ninety idiopathic HFS patients and 90 BEB patients were enrolled. The anxiety and de...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Neuropsychiatr Dis Treat |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6304258/ https://ncbi.nlm.nih.gov/pubmed/30587995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S181820 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|